Literature DB >> 10658628

Overexpression of alpha2C-adrenoceptors impairs water maze navigation.

M Björklund1, J Sirviö, M Riekkinen, J Sallinen, M Scheinin, P Riekkinen.   

Abstract

We investigated the role of overexpression of alpha2C-adrenoceptors in water maze navigation in mice transgenically manipulated to have a threefold overexpression of the alpha2C-adrenoreceptors. Alpha2C-adrenoreceptors overexpressing mice swam more in the peripheral annulus of the pool and did not find the hidden escape platform as well as the wild type control mice. A subtype-nonselective alpha2-adrenoreceptor antagonist, atipamezole (ATI, 1000 microg/kg, s.c.), fully reversed the deficit in platform finding and search strategy in overexpressing mice. Noradrenaline depletion (-95%) induced by N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) did not impair platform finding of wild type or overexpressing mice. The DSP-4 lesion slightly increased swimming in the peripheral annulus in wild type mice, but not in overexpressing mice. The DSP-4 lesion produced a dissociable effect on the action of atipamezole to improve platform finding and search strategy in overexpressing mice: atipamezole did not alleviate the platform finding deficit in DSP-4 lesioned overexpressing mice, but normalized their abnormal search strategy. These results suggest that the abnormal search pattern and deficit in the accuracy of platform finding are mediated by constitutive activity of overexpressed alpha2C-adrenoreceptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10658628     DOI: 10.1016/s0306-4522(99)00428-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

1.  Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.

Authors:  Kwakye Peprah; Xue Y Zhu; Suresh V K Eyunni; Vincent Setola; Bryan L Roth; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2011-12-22       Impact factor: 3.641

2.  Changes in postnatal norepinephrine alter alpha-2 adrenergic receptor development.

Authors:  J D Sanders; H K Happe; D B Bylund; L C Murrin
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

3.  Behavioral and neurochemical alterations in mice lacking the RNA-binding protein translin.

Authors:  Joel M Stein; Wayland Bergman; Yanshan Fang; Lakesha Davison; Colleen Brensinger; Michael B Robinson; Norman B Hecht; Ted Abel
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

4.  Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior.

Authors:  H M Fentress; R Klar; J J Krueger; T Sabb; S N Redmon; N M Wallace; J K Shirey-Rice; M K Hahn
Journal:  Genes Brain Behav       Date:  2013-10-09       Impact factor: 3.449

5.  Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine.

Authors:  Jenna S Franowicz; Lynn E Kessler; Catherine M Dailey Borja; Brian K Kobilka; Lee E Limbird; Amy F T Arnsten
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

6.  Molecular determinants of behavioral changes induced by neonatal ketamine and dexmedetomidine application.

Authors:  Mediha Turktan; Mehmet Bertan Yilmaz; Zehra Hatipoglu; Seda Ilgaz; Esma Deniz Barc; Hale Oksuz; Kubra Akillioglu; Dilek Ozcengiz
Journal:  J Neural Transm (Vienna)       Date:  2019-09-14       Impact factor: 3.575

Review 7.  Lurasidone for the treatment of bipolar depression: an evidence-based review.

Authors:  Rachel Franklin; Sam Zorowitz; Andrew K Corse; Alik S Widge; Thilo Deckersbach
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-19       Impact factor: 2.570

8.  Effects of caffeine or RX821002 in rats with a neonatal ventral hippocampal lesion.

Authors:  Guy Sandner; Marie-Josée Angst; Thierry Guiberteau; Blandine Guignard; Astrid Nehlig
Journal:  Front Behav Neurosci       Date:  2014-01-28       Impact factor: 3.558

Review 9.  Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective.

Authors:  Madeleine Monique Uys; Mohammed Shahid; Brian Herbert Harvey
Journal:  Front Psychiatry       Date:  2017-08-14       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.